Document is current
Any future updates will be listed below
-
Authors
Korkmaz, Funda
Sims, Steven https://orcid.org/0000-0002-1636-084X
Sen, Fazilet
Sultana, Farhath
Laurencin, Victoria
Cullen, Liam
Pallapati, Anusha
Liu, Avi
Chen, Ronald https://orcid.org/0009-0008-9152-8666
Rojekar, Satish
Pevnev, Georgii
Cheliadinova, Uliana
Vasilyeva, Darya
Burganova, Guzel https://orcid.org/0000-0002-7204-7268
Macdonald, Anne
Saxena, Mansi
Goosens, Ki https://orcid.org/0000-0002-5246-2261
Rosen, Clifford J.
Barak, Orly
Lizneva, Daria
Gumerova, Anisa
Ye, Keqiang https://orcid.org/0000-0002-7657-8154
Ryu, Vitaly
Yuen, Tony https://orcid.org/0009-0001-6000-8827
Frolinger, Tal https://orcid.org/0000-0002-2066-6649
Zaidi, Mone https://orcid.org/0000-0001-5911-9522
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (U19 AG060917, R01 AG071870, R01 AG074092, U01 AG073148, R01 AG071870, R01 AG074092, U01 AG073148, U19 AG060917, R01 DK113627)
- License Information
-
More Information
Article History
Received: 17 February 2024
Revised: 23 October 2024
Accepted: 4 November 2024
First Online: 15 November 2024
Competing interests
: MZ is inventor on issued and pending patients on the use of FSH as a target for osteoporosis, obesity and Alzheimer’s disease. MZ, SR and TY are inventors on a pending patent on an FSH antibody that is formulated at ultrahigh concentration. The patents will be held by the Icahn School of Medicine at Mount Sinai, and MZ, SR and TY would be recipient of royalties, per institutional policy. The other authors declare no competing financial interests.
: All methods were performed in accordance with the relevant guidelines and regulations. Animal handling and use were compliant with the National Institutes of Health’s Guide for the Care and Use of Laboratory Animals, and approved by the Icahn School of Medicine at Mount Sinai Institutional Animal Care and Use Committee (IACUC Approval # 2018-0047).
